Cargando…
Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
Gene therapy for β-globinopathies, particularly β-thalassemia and sickle cell anemia, holds promise for the future as a definitive corrective approach for these common and debilitating disorders. Correction of the β-globinopathies using lentivirus vectors carrying the β- or γ-globin genes and elemen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
TheScientificWorldJOURNAL
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763711/ https://www.ncbi.nlm.nih.gov/pubmed/20419277 http://dx.doi.org/10.1100/tsw.2010.67 |